BLOG / 🇺🇸 United States · · daily

Contract Option Exercises — August 11, 2026

Contract Option Exercises

By Gunpowder Editorial ·

2 total filings analysed

Executive Summary

Across these two civilian agency contracts totaling $269.3 million, NASA's Restore-L mission contract with LANTERIS SPACE LLC ($139.8M) and the VA's medical disability exam delivery order with Leidos Holdings subsidiary QTC Medical Services ($129.5M) both signal stable, execution-phase revenue streams with low remaining risk.

The 0/2 defense split highlights exclusive civilian sector exposure, with the VA contract nearing 85% completion and the LANTERIS contract having $69M already outlaid. The highest-conviction signal is the VA contract's high outlay rate, confirming near-complete cash conversion for Leidos. Key risks include LANTERIS's foreign ownership status in a sensitive space program and the VA contract's single-year performance period limiting forward visibility.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior Contract Option Exercises digest from August 04, 2026.

Investment Signals (3)

  • Leidos/VA Contract Shows Strong Execution – $110.7M of $129.5M Already Outlaid (HIGH)

    QTC Medical Services (Leidos subsidiary) has secured $110.7M in cash from a $129.5M firm-fixed-price VA delivery order, representing 85% completion with low remaining execution risk.

  • LANTERIS SPACE's Foreign Ownership in NASA's Restore-L Program Poses Regulatory Risk (MEDIUM)

    The $139.8M NASA contract for sensitive spacecraft bus manufacturing and on-orbit refueling involves a foreign-owned entity, creating potential for future policy-driven restrictions or contract modifications under CFIUS review.

  • Restore-L Mission Milestones Could Drive Future Space Servicing Awards for LANTERIS SPACE (MEDIUM)

    Successful execution of the 10-year Restore-L refueling mission positions LANTERIS SPACE for follow-on NASA and commercial on-orbit servicing contracts, building on $69M already outlayed.

Risk Flags (3)

  • Regulatory [HIGH RISK]

    LANTERIS SPACE LLC is foreign-owned and holds a $139.8M NASA contract for spacecraft bus manufacturing and on-orbit refueling, a strategically sensitive space capability. Changes in U.S. foreign-ownership rules or CFIUS review could disrupt contract execution.

  • Execution [MEDIUM RISK]

    LANTERIS SPACE's firm-fixed-price contract transfers cost overrun risk to the contractor for the $139.8M Restore-L mission. The 10+ year performance period (2016-2027) leaves exposure to technical challenges and schedule delays.

  • Concentration [MEDIUM RISK]

    Leidos Holdings' VA contract portfolio shows single-year concentration risk: the $129.5M QTC Medical Services delivery order is a one-year award ending in 2021, and no follow-on has been identified in this data set.

Opportunities (2)

  • Successful completion of the Restore-L on-orbit refueling mission opens the door for LANTERIS SPACE to capture NASA and commercial contracts for satellite servicing, debris removal, and refueling – a nascent but growing market validated by this $139.8M award.

  • VA medical disability exams are mandated under Public Law 104-275, ensuring sustained funding. QTC Medical Services' strong execution on the $129.5M Pacific region contract positions Leidos for follow-on awards when the Region 4 contract is re-competed.

Sector Themes (2)

  • 100% of the $269.3M in option exercises for this period are from NASA and VA, with zero defense exposure. Both contracts show high outlay rates (42-85%), indicating the government is prioritizing completing existing civilian contracts over new defense awards during this period.

  • NASA's $139.8M investment in LANTERIS SPACE for Restore-L refueling signals growing government commitment to space servicing capabilities, with the contract spanning hardware manufacturing and full integration.

Watch List (3)

  • 👁

    {"entity" => "LANTERIS SPACE LLC", "reason" => "Foreign ownership in a $139.8M NASA spacecraft contract creates regulatory vulnerability; success on Restore-L could make it a takeover target or licensor of technology.", "trigger" => "CFIUS review initiation, NDAA provisions on foreign-owned space contractors, Restore-L mission completion date"}

  • 👁

    {"entity" => "Leidos Holdings Inc.", "reason" => "VA medical exam contract is 85% complete ($110.7M outlaid); lack of follow-on in this data set raises revenue replacement risk for the Pacific region.", "trigger" => "VA Region 4 contract re-compete RFP release, Leidos quarterly earnings call VA segment commentary"}

  • 👁

    {"entity" => "NASA Goddard Space Flight Center", "reason" => "Restore-L is NASA's flagship on-orbit servicing mission; delays or budget cuts would affect LANTERIS SPACE's revenue stream and signal broader space servicing timeline shifts.", "trigger" => "NASA Inspector General report on Restore-L, FY2027 NASA budget request, Restore-L milestone delays"}

Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 2 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Contract Option Exercises

🇺🇸 More from United States

View all →